Skip to main content

An official website of the United States government

PromethION Flow Cell Packs and Ligation Sequencing Kits

Waiver type - Procurement: Nonavailability

Agency: NATIONAL INSTITUTES OF HEALTH (7529) • Product Service Code (PSC) : 6640 | Last Modified: 08/08/2024

Procurement Summary

The purpose of this acquisition is to purchase the PromethIONion Flow cells (or equal). Nanopore PromethION flow cells, developed by Oxford Nanopore Technologies, represent a groundbreaking advancement in the field of genomics. Nanopore sequencing technology enables the direct, real-time analysis of long DNA and RNA molecules as they pass through nanopores. This method offers significant advantages over traditional short-read sequencing technologies, including the ability to generate ultra-long reads, high throughput, and real-time data acquisition. PromethION, one of the most powerful platforms within the nanopore sequencing family, is designed for large-scale, high-throughput applications, making it ideal for comprehensive genomic studies.

Did / Will the solicitation include one of the standard BAA provisions announcing the agency’s intention to provide a price preference for domestic end products and construction material?

Yes

Was a sources sought or Request for Information issued?

Yes

OMB Determination

Consistent with Policy

Product

LABORATORY EQUIPMENT AND SUPPLIES

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Date Submitted

07/24/2024

Procurement Instrument Identifier (PIID)

N/A

Solicitation ID

N/A

Procurement Stage

Pre-solicitation

Expected Maximum Duration of the Proposed Waiver

Instant Delivery Only

Waiver Coverage

Individual Waiver

Funding Agency

NATIONAL INSTITUTES OF HEALTH